<ѻý>The Year SGLT2 Inhibitors Became Full-Fledged Heart Failure Drugsѻý> Treatment no longer limited by ejection fraction Dec 27, 2022
<ѻý>No Blaming Common Antihypertensives for Pancreatic Cancer, Study Suggestsѻý> Some reassurance on widely prescribed dihydropyridine calcium channel blockers Dec 15, 2022
<ѻý>TAVR at 20: How Much Longer Will Medicare Mandate a Registry?ѻý> Change is a-comin' but interventionalists debate just how soon that should be and what comes next Dec 08, 2022
<ѻý>Heart Failure From Meth Use: Growing Beast Lurks in the Shadowsѻý> Exact scope of problem still unknown due to low clinician awareness Dec 02, 2022
<ѻý>Early Cardiac Amyloidosis Still Bad News Without Treatmentѻý> Observational study supports treating even asymptomatic patients Nov 16, 2022
<ѻý>Upfront ECMO Disappoints for Cardiogenic Shockѻý> High-cost procedure not yet justified as an early strategy Nov 07, 2022
<ѻý>Moving Fast on HF Drugs After Acute Hospitalization Holds Big Outcome Benefitѻý> Randomized trial shows advantages across heart failure spectrum Nov 07, 2022
<ѻý>Experts Agree Intravenous Iron Shows Promise for Heart Failure Patientsѻý> While findings were not significant, the study was impacted by COVID lockdowns, researcher says Nov 07, 2022
<ѻý>Decision-Support Tool Enhances Outcomes for Heart Failure Patients in the EDѻý> Pathways for HF patients picked for early discharge versus admission Nov 06, 2022
<ѻý>Not So Cool After All: No CV Benefit With Lower-Temp Dialysate in Hemodialysisѻý> Some patients in MyTEMP trial even complained cooler dialysate was "worst possible feeling" Nov 06, 2022
<ѻý>Furosemide Holds Up to Newer, Stronger Loop Diuretic During HF Hospitalizationѻý> Preference for mainstay decongestant versus torsemide likely unchanged after TRANSFORM-HF study Nov 05, 2022
<ѻý>Empagliflozin Protects At-Risk Patients From CKD Progressionѻý> Also cut risk for cardiovascular-related death and worsening kidney function Nov 04, 2022
<ѻý>Outpatient Centers Cautiously Open Doors to Surgery for People With Cardiac Devicesѻý> Will those with CIEDs become regular patients at ambulatory surgery centers within a decade? Oct 25, 2022
<ѻý>Despite Exciting Newcomer Drugs, Uptake of HF Meds Still Meek Across Oceansѻý> U.S. not alone in slow initiation, low target-dose achievement, and early discontinuation Oct 14, 2022
<ѻý>Lower Entresto Doses Suffice in the Real Worldѻý> Reassuring findings for patients who don't tolerate the maximum ARNI dose Oct 10, 2022
<ѻý>FDA Approves At-Home Furosemide for Heart Failureѻý> Strong diuretic to become available outside the hospital setting Oct 10, 2022
<ѻý>Salt Pills During Diuresis: Acute HF Patients Neither Helped Nor Harmedѻý> Small randomized trial challenges conventional thinking about sodium Oct 05, 2022
<ѻý>The Search Is On for Another Xeno Heart Transplant Recipientѻý> Transplant surgeons discuss testing the concept in more humans Oct 04, 2022
<ѻý>Urgency to Expand SGLT2i Use in HF Heightened by More DELIVER Dataѻý> Analyses continue to support wider adoption of dapagliflozin, researchers say Oct 03, 2022
<ѻý>Growing Calls to Marry HF Specialists With Cardiac Critical Careѻý> Cardiac ICU staffing issues require a multidisciplinary team approach, some say Oct 02, 2022
<ѻý>MitraClip G4 Sets the Bar Higher for Transcatheter Edge-to-Edge Repairѻý> Post-approval study suggests growing pool of TEER-suitable patients Sep 18, 2022
<ѻý>Presumed Clinical Benefits of TAVR Cerebral Protection Remain Unprovenѻý> Large trial comes up short in proving a definitive benefit to debris filters Sep 17, 2022
<ѻý>Aggressive Alcohol Septal Ablation for HCM Holds Up, Pacemakers Notwithstandingѻý> Complication of ablation not associated with worse outcomes at 5 years Sep 14, 2022
<ѻý>Milestone Reached for SGLT2 Inhibitor Aimed at Heart Attack Populationѻý> Good signals in people with large acute MIs at risk of developing heart failure Aug 30, 2022
<ѻý>Transradial Access for Heart Procedures Saves Lives in Most Definitive Study Yetѻý> Approach beats coronary access through the thigh Aug 29, 2022
<ѻý>Finally, A Foundational Heart Failure Drug That Works Across the Spectrum of EFѻý> SGLT2 inhibitor shines in landmark DELIVER trial Aug 27, 2022
<ѻý>ADVOR Backs Add-On Acetazolamide for Cutting Congestion in Decompensated HFѻý> Exclusion of patients on SGLT2 inhibitors was a major trial limitation, expert says Aug 27, 2022
<ѻý>Mass Cardiovascular Testing May Add Years for Some Menѻý> Mixed results after the DANCAVAS program from Denmark Aug 27, 2022
<ѻý>No Detrimental Impact on Cognition With Entresto for Heart Failureѻý> Cost may be reason for underutilization, rather than concerns about cognition, expert noted Aug 26, 2022
<ѻý>No Worsening Cardiac Dysfunction in Long COVIDѻý> Other harms likely contribute to dyspnea, HF after COVID-19 hospitalization Aug 05, 2022
<ѻý>Heart Disease Will Surge Over the Coming Decadesѻý> Worsening racial disparities are also projected Aug 01, 2022
<ѻý>Fluid Therapy Showdown in Cardiac Surgery Disfavors Albuminѻý> Major adverse events not reduced, and some complications increased Jul 19, 2022
<ѻý>Bye-Bye, 'Life's Simple 7': AHA Redefines Cardiovascular Health by Adding Sleepѻý> New metrics and scoring algorithm for heart health in children and adults Jun 29, 2022
<ѻý>Which Advanced HF Patients Are Entresto-Intolerant in the Real World?ѻý> 1 in 6 dropped out from the LIFE trial because of side effects Jun 27, 2022
<ѻý>Heart Failure Drugs Can Be Unaffordable on Medicare, Study Findsѻý> Older adults are subject to cost-sharing and other medication coverage restrictions Jun 21, 2022
<ѻý>TAVR Pacemaker Rate Dips to Single Digits Nationwide, but Outlier Hospitals Remainѻý> Do worst-performing sites need more education about best practices? Jun 12, 2022
<ѻý>Fate of Transcatheter Tricuspid Devices: Will it Be Repair or Replacement?ѻý> Many unanswered questions remain regarding devices for tricuspid regurgitation Jun 11, 2022
<ѻý>TAVR Devices Keep Changing -- Is This Really Helping Patients?ѻý> Clinical outcomes are headed in the right direction, but better research is needed Jun 10, 2022
<ѻý>Good News for Heart Failure Patients Getting COVID Booster Shotsѻý> Group saw lower risks for hospitalization, ICU admission, death versus the unvaccinated Jun 09, 2022
<ѻý>TAVR for Aortic Regurgitation Off to a Good Start in the Real Worldѻý> Yet some growing pains remain for the Jenavalve Trilogy May 21, 2022